Copyright 2024 All rights reserved.
PR Center
Development of safe stem cell therapy for
immune rejection
We are working to improve
the quality of life in various fields.
PR Center
IP Portfolio
| Title | Regi/App No. (Date) | Remarks |
|---|---|---|
|
Compartment Unit for Cell Culture and Array having the same
Regi/App No. (Date) 10-1179553 (2012.08.29)
Remarks KR Registered
|
10-1179553 (2012.08.29) | KR Registered |
|
Array Apparatus for Separation of Single Cell
Regi/App No. (Date) 10-1252829 (2013.04.03)
Remarks KR Registered
|
10-1252829 (2013.04.03) | KR Registered |
|
A Method for Mass Production of Proteins from Mesenchymal Stem Cells
Regi/App No. (Date) 10-1566450 (2015.10.30)
Remarks KR Registered
|
10-1566450 (2015.10.30) | KR Registered |
|
A Method for Mass Production of Proteins from Mesenchymal Stem Cells
Regi/App No. (Date) PCT/KR2016/003421 (2016.04.01)
Remarks PCT Applied
|
PCT/KR2016/003421 (2016.04.01) | PCT Applied |
|
A Method for Mass Production of Proteins from Mesenchymal Stem Cells
Regi/App No. (Date) 11,077,145 (2021.08.03)
Remarks US Registered
|
11,077,145 (2021.08.03) | US Registered |
|
A Method for Mass Production of Proteins from Mesenchymal Stem Cells
Regi/App No. (Date) 6609034 (2019.11.01)
Remarks JP Registered
|
6609034 (2019.11.01) | JP Registered |
|
Culture Media Composition for Promoting Stem Cell Proliferation comprising Plant Extracts
Regi/App No. (Date) 10-2014-0070804 (2014.06.11)
Remarks KR Applied
|
10-2014-0070804 (2014.06.11) | KR Applied |
|
A Composition for Cell Cryopreservation comprising Culture Media from Human Mesenchymal Stem Cells
Regi/App No. (Date) 10-2018609 (2019.08.30)
Remarks KR Registered
|
10-2018609 (2019.08.30) | KR Registered |
|
A Composition for Cell Cryopreservation comprising Culture Media from Human Mesenchymal Stem Cells
Regi/App No. (Date) PCT/KR2018/003579 (2018.03.27)
Remarks PCT Applied
|
PCT/KR2018/003579 (2018.03.27) | PCT Applied |
|
Cell Line Consecutively Expressing HLA-G Protein and Method for Preparing the same
Regi/App No. (Date) 10-1980726 (2019.05.15)
Remarks KR Registered
|
10-1980726 (2019.05.15) | KR Registered |
|
Cell Line Consecutively Expressing HLA-G Protein and Method for Preparing the same
Regi/App No. (Date) PCT/KR2019/005072 (2019.04.26)
Remarks PCT Applied
|
PCT/KR2019/005072 (2019.04.26) | PCT Applied |
|
Cell Line Consecutively Expressing HLA-G Protein and Method for Preparing the same
Regi/App No. (Date) 11,566,220 (2023.01.31)
Remarks US Registered
|
11,566,220 (2023.01.31) | US Registered |
|
Cell Line Consecutively Expressing HLA-G Protein and Method for Preparing the same
Regi/App No. (Date) 6977051 (2021.11.121)
Remarks JP Registered
|
6977051 (2021.11.121) | JP Registered |
|
Production Methods of Immune-tolerant Extracellular Vesicle containing Lactate Dehydrogenase B and Peroxisome proliferator-activated receptor gamma coactivator 1-alpha and Therapeutic Composition for Anti-Cancer thereof
Regi/App No. (Date) 10-2049505 (2019.11.21)
Remarks KR Registered
|
10-2049505 (2019.11.21) | KR Registered |
|
Production Methods of Immune-tolerant Extracellular Vesicle containing Lactate Dehydrogenase B and Peroxisome proliferator-activated receptor gamma coactivator 1-alpha and Therapeutic Composition for Anti-Cancer thereof
Regi/App No. (Date) PCT/KR2019/011044 (2019.08.29)
Remarks PCT Applied
|
PCT/KR2019/011044 (2019.08.29) | PCT Applied |